Meridian Bioscience Q3 Profit Down 97%, Reiterates FY17 Outlook - Quick Facts

Meridian Bioscience Inc. (VIVO) reported a 97 plunge in profit for the third quarter from last year on slightly lower revenues and a goodwill impairment charge.

from RTT - Earnings http://ift.tt/2h5DmIh
via IFTTT